| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 6.608 | 1.307 | 0 | 0 | 8.198 | 11.329 | 39.186 |
| Total Income - EUR | - | - | - | 6.608 | 1.307 | 0 | 0 | 8.198 | 11.357 | 40.203 |
| Total Expenses - EUR | - | - | - | 3.714 | 1.325 | 290 | 1.552 | 10.718 | 34.099 | 51.769 |
| Gross Profit/Loss - EUR | - | - | - | 2.894 | -18 | -290 | -1.552 | -2.519 | -22.741 | -11.566 |
| Net Profit/Loss - EUR | - | - | - | 2.783 | -31 | -290 | -1.552 | -2.519 | -22.855 | -11.969 |
| Employees | - | - | - | 1 | 1 | 1 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Alprolife S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 3.376 | 707 | 31 | 15 | 38.198 | 47.746 | 38.528 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 32.241 | 38.704 | 33.372 |
| Receivables | - | - | - | 3.223 | 702 | 0 | 0 | 5.793 | 8.201 | 3.302 |
| Cash | - | - | - | 153 | 5 | 31 | 15 | 164 | 841 | 1.854 |
| Shareholders Funds | - | - | - | 2.826 | 11 | -279 | -1.825 | -4.350 | -27.192 | -39.009 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 558 | 696 | 310 | 1.840 | 42.548 | 74.969 | 77.556 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Alprolife S.r.l.